Ariel Hurley - Nov 16, 2021 Form 4 Insider Report for Blueprint Medicines Corp (BPMC)

Role
Principal Accounting Officer
Signature
/s/ Tracey McCain, Attorney-in-Fact
Stock symbol
BPMC
Transactions as of
Nov 16, 2021
Transactions value $
-$206,811
Form type
4
Date filed
11/18/2021, 03:06 PM
Previous filing
Sep 27, 2021
Next filing
Mar 3, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BPMC Common Stock Options Exercise $1.31K +700 +6.93% $1.87* 10.8K Nov 16, 2021 Direct F1
transaction BPMC Common Stock Options Exercise $5.72K +650 +6.02% $8.80* 11.4K Nov 16, 2021 Direct F1
transaction BPMC Common Stock Options Exercise $9.01K +600 +5.24% $15.01 12K Nov 16, 2021 Direct F1
transaction BPMC Common Stock Sale -$223K -1.95K -16.19% $114.28 10.1K Nov 16, 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BPMC Stock Option (Right to Buy) Options Exercise $0 -700 -16.08% $0.00 3.65K Nov 16, 2021 Common Stock 700 $1.87 Direct F1, F2
transaction BPMC Stock Option (Right to Buy) Options Exercise $0 -650 -47.65% $0.00 714 Nov 16, 2021 Common Stock 650 $8.80 Direct F1, F3
transaction BPMC Stock Option (Right to Buy) Options Exercise $0 -600 -15.79% $0.00 3.2K Nov 16, 2021 Common Stock 600 $15.01 Direct F1, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Effected pursuant to a trading plan adopted on March 12, 2021 pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.
F2 This option was granted on October 8, 2014 and is fully vested as of the date hereof.
F3 This option was granted on February 10, 2015 and is fully vested as of the date hereof.
F4 This option was granted on February 3, 2016 and is fully vested as of the date hereof.